Top Markets
Coin of the day
AVAX Technologies, Inc. AVAX Technologies, Inc.

AVAX Technologies, Inc.

AVXT
株式のランク #41955
AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on... AVAX Technologies, Inc. is an emerging biopharmaceutical company focused on pioneering autologous cell vaccine methods for cancer therapy. Its pipeline includes lead candidates M-VAX, for melanoma, and O-VAX, targeting ovarian cancer, both of which have successfully concluded Phase II clinical trials. The firm is also developing LungVax, a potential treatment for non-small cell lung cancer. Established in 1990, the Philadelphia, Pennsylvania-based entity initially operated as Walden Laboratories, Inc. before adopting its current name, AVAX Technologies, Inc., in March 1996.
株価
$0.00001
最終同期: 2025-12-30
時価総額
$6.89K
変化(1日)
0.00%
変化(1年)
0.00%
US
取引 AVAX Technologies, Inc. (AVXT)

カテゴリー

AVAX Technologies, Inc.(AVXT)の株価履歴
終値の最高値: $0.00 (2025-12-01)

終値の最安値: $5.70 (1997-05-01)
AVAX Technologies, Inc. の株価履歴(1997 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 0.00%
2025 0.00%
2024 -90.00%
2023 0.00%
2022 -29.03%
2021 -92.02%
2020 29.21%
2019 62.70%
2018 -57.93%
2017 -45.69%
2016 -85.27%
2015 184.66%
2014 150.18%
2013 -39.36%
2012 -82.52%
2011 -23.65%
2010 -61.01%
2009 671.71%
2008 -87.28%
2007 -15.34%
2006 -53.45%
2005 27.11%
2004 26.14%
2003 -8.09%
2002 -67.56%
2001 -85.17%
2000 -25.37%
1999 125.74%
1998 -36.11%
1997 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$527.87 33.33%
US
$873.57 35.10%
NL
$736.38 7.69%
CH
$263.09 18.09%
BE
$1.07K -7.52%
KR